QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 380 Cr.
- Current Price ₹ 197
- High / Low ₹ 200 / 69.0
- Stock P/E 35.4
- Book Value ₹ 53.9
- Dividend Yield 0.25 %
- ROCE 12.9 %
- ROE 10.4 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 56.4%
Cons
- Stock is trading at 3.65 times its book value
- Company has a low return on equity of 12.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -5.56%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| 122 | 156 | 173 | 183 | |
| 104 | 130 | 147 | 155 | |
| Operating Profit | 18 | 25 | 26 | 28 |
| OPM % | 15% | 16% | 15% | 15% |
| 0 | 2 | 1 | 1 | |
| Interest | 3 | 5 | 7 | 7 |
| Depreciation | 3 | 4 | 4 | 5 |
| Profit before tax | 12 | 19 | 16 | 17 |
| Tax % | 26% | 27% | 27% | |
| 9 | 14 | 12 | 13 | |
| EPS in Rs | 4.66 | 6.26 | 5.24 | 5.56 |
| Dividend Payout % | 0% | 74% | 95% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| 1 Year: | 98% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 18 | 18 | 19 |
| Reserves | 61 | 72 | 85 |
| 35 | 60 | 74 | |
| 22 | 40 | 34 | |
| Total Liabilities | 135 | 190 | 213 |
| 24 | 52 | 55 | |
| CWIP | 2 | 3 | 3 |
| Investments | 2 | 3 | 5 |
| 108 | 131 | 150 | |
| Total Assets | 135 | 190 | 213 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 1 | 19 | 19 | |
| -3 | -45 | -20 | |
| 0 | 27 | 1 | |
| Net Cash Flow | -1 | 1 | 0 |
| Free Cash Flow | 1 | 19 | 19 |
| CFO/OP | 26% | 97% | 93% |
Ratios
Consolidated / View Standalone
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 124 | 136 | 142 |
| Inventory Days | 172 | 176 | 181 |
| Days Payable | 90 | 76 | 73 |
| Cash Conversion Cycle | 205 | 236 | 251 |
| Working Capital Days | 148 | 100 | 93 |
| ROCE % | 17% | 13% |
Insights
In beta| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Institutional Clients (Pharma Companies) Clients |
|
||
| Number of B2B Health Camps Conducted Camps |
|||
| Number of Product SKUs SKUs |
|||
| Number of Trained DMLT Field Technicians DMLTs |
|||
| Patients Served (Screened / On Digital Platform) Patients |
|||
| Serviceable PIN Codes PIN codes |
|||
| Total Employees / Professionals Employees |
|||
Extracted by Screener AI
Documents
Announcements
-
Press Release
- QMS and HCAH signed definitive documents to merge PSP businesses into Saarathi, targeting 160+ programs.
-
Acquisition
- 25 Sept 2026 board approved composite scheme demerging healthcare services business into Saarathi and BeamOptics acquisition.
-
Scheme of Arrangement
- Board approved healthcare demerger, merger agreements, and 100% acquisition of BeamOptics Scientific on 25 September 2026.
-
Memorandum of Understanding/Agreements
- Board approved composite scheme demerging healthcare services into Saarathi and acquisition of BeamOptics Scientific on 25 Sep 2026.
-
Agreements
- Board approved healthcare services demerger into Saarathi and acquisition of 100% BeamOptics on 25 September 2026.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
-
Annual Report 2023
from nse
Concalls
-
Aug 2026Transcript PPT REC
-
Aug 2026PPT
-
Jun 2026Transcript
-
Feb 2026PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.